RESEARCH TRIANGLE PARK, N.C., July 28, 2011 (GLOBE NEWSWIRE) -- Tranzyme Pharma (Nasdaq:TZYM), a late-stage biopharmaceutical company, today announced that Vipin Garg, President and CEO, and Richard Eisenstadt, CFO, will present at the Canaccord Genuity Annual Growth Conference taking place in Boston August 9-11, 2011 at the InterContinental Hotel. Tranzyme's presentation is scheduled for Tuesday, August 9 at 10:00 A.M. ET in the San Francisco Room.
